Get Diamond plan for FREE

    logo

    HeartBeam, Inc. (BEAT)

    Price:

    1.08 USD

    ( - -0.05 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    BEAT
    Name
    HeartBeam, Inc.
    Industry
    Medical - Healthcare Information Services
    Sector
    Healthcare
    Price
    1.080
    Market Cap
    37.057M
    Enterprise value
    58.906M
    Currency
    USD
    Ceo
    Robert P. Eno
    Full Time Employees
    21
    Website
    heartbeam.com
    Ipo Date
    2021-11-11
    City
    Santa Clara
    Address
    2118 Walsh Avenue

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    GE HealthCare Technologies Inc.

    VALUE SCORE:

    5

    Symbol
    GEHC
    Market Cap
    33.363B
    Industry
    Medical - Healthcare Information Services
    Sector
    Healthcare

    2nd position

    CareCloud, Inc.

    VALUE SCORE:

    9

    Symbol
    CCLD
    Market Cap
    114.904M
    Industry
    Medical - Healthcare Information Services
    Sector
    Healthcare

    The best

    Progyny, Inc.

    VALUE SCORE:

    9

    Symbol
    PGNY
    Market Cap
    1.992B
    Industry
    Medical - Healthcare Information Services
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -1.796
    P/S
    0
    P/B
    8.738
    Debt/Equity
    0
    EV/FCF
    -2.169
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0
    Earnings yield
    -0.557
    Debt/assets
    0
    FUNDAMENTALS
    Net debt/ebidta
    0.158
    Interest coverage
    0
    Research And Developement To Revenue
    0
    Intangile to total assets
    0
    Capex to operating cash flow
    -0.013
    Capex to revenue
    0
    Capex to depreciation
    9.318
    Return on tangible assets
    -3.401
    Debt to market cap
    0
    Piotroski Score
    1.000
    FUNDAMENTALS
    PEG
    -0.332
    P/CF
    -2.376
    P/FCF
    -2.378
    RoA %
    -340.144
    RoIC %
    -491.487
    Gross Profit Margin %
    0
    Quick Ratio
    2.980
    Current Ratio
    2.980
    Net Profit Margin %
    0
    Net-Net
    0.096
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.461
    Revenue per share
    0
    Net income per share
    -0.601
    Operating cash flow per share
    -0.455
    Free cash flow per share
    -0.461
    Cash per share
    0.149
    Book value per share
    0.124
    Tangible book value per share
    0.124
    Shareholders equity per share
    0.124
    Interest debt per share
    0
    TECHNICAL
    52 weeks high
    3.480
    52 weeks low
    0.910
    Current trading session High
    1.170
    Current trading session Low
    1.080
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo
    Country
    US
    Sector
    Technology
    Industry
    Semiconductors
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -8.590
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -46.919
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.628
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    55.946
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.696
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.019
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.133
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -56.527
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    37.569
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000
    DESCRIPTION

    HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

    NEWS
    https://images.financialmodelingprep.com/news/heartbeam-inc-beat-q2-2025-earnings-call-transcript-20250813.jpg
    HeartBeam, Inc. (BEAT) Q2 2025 Earnings Call Transcript

    seekingalpha.com

    2025-08-13 21:17:26

    HeartBeam, Inc. (NASDAQ:BEAT ) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Ian Scargill - Corporate Participant Robert P. Eno - CEO, Chief Business Officer & Director Timothy Cruickshank - Chief Financial Officer Conference Call Participants William Sutherland - The Benchmark Company, LLC, Research Division Operator Greetings, and welcome to the HeartBeam Second Quarter 2025 Financial Results Conference Call.

    https://images.financialmodelingprep.com/news/heartbeam-reports-second-quarter-2025-results-20250813.jpg
    HeartBeam Reports Second Quarter 2025 Results

    businesswire.com

    2025-08-13 16:01:00

    SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Second Quarter 2025 Results.

    https://images.financialmodelingprep.com/news/heartbeam-to-host-second-quarter-2025-results-conference-call-20250730.jpg
    HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern Time

    businesswire.com

    2025-07-30 07:00:00

    SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern Time.

    https://images.financialmodelingprep.com/news/heartbeam-wins-industry-innovation-award-for-advancing-remote-cardiac-20250722.jpg
    HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care With Groundbreaking ECG Technology

    businesswire.com

    2025-07-22 07:00:00

    SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care with Groundbreaking ECG Technology.

    https://images.financialmodelingprep.com/news/heartbeam-to-present-at-the-iaccess-alpha-virtual-best-20250617.jpg
    HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025

    businesswire.com

    2025-06-17 07:00:00

    SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025.

    https://images.financialmodelingprep.com/news/heartbeam-inc-beat-q1-2025-earnings-call-transcript-20250513.jpg
    HeartBeam, Inc. (BEAT) Q1 2025 Earnings Call Transcript

    seekingalpha.com

    2025-05-13 22:40:29

    HeartBeam, Inc. (NASDAQ:BEAT ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Rob Eno - CEO Tim Cruickshank - CFO Larry Holub - IR, MZ Group Conference Call Participants Bill Sutherland - The Benchmark Company Leo Carpio - Joseph Gunnar Operator Greetings and welcome to the HeartBeam First Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

    https://images.financialmodelingprep.com/news/heartbeam-reports-first-quarter-2025-results-20250513.jpg
    HeartBeam Reports First Quarter 2025 Results

    businesswire.com

    2025-05-13 16:01:00

    SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports First Quarter 2025 Results.

    https://images.financialmodelingprep.com/news/heartbeam-announces-two-new-us-patents-powering-forward-its-20250506.jpg
    HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio

    businesswire.com

    2025-05-06 07:00:00

    SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio.

    https://images.financialmodelingprep.com/news/heartbeam-appoints-ceo-robert-eno-to-board-of-directors-20250505.jpg
    HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

    businesswire.com

    2025-05-05 07:00:00

    SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth.

    https://images.financialmodelingprep.com/news/heartbeam-to-host-first-quarter-2025-results-conference-call-on-20250501.jpg
    HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time

    businesswire.com

    2025-05-01 08:31:00

    SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time.

    https://images.financialmodelingprep.com/news/heartbeam-successfully-meets-clinical-endpoints-in-pivotal-study-for-20250429.jpg
    HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology

    businesswire.com

    2025-04-29 08:31:00

    SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology.

    https://images.financialmodelingprep.com/news/heartbeam-and-accurkardia-announce-strategic-collaboration-to-advance-cardiac-20250424.jpg
    HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation

    businesswire.com

    2025-04-24 08:31:00

    SANTA CLARA, Calif. & NEW YORK--(BUSINESS WIRE)--HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation.

    https://images.financialmodelingprep.com/news/heartbeam-inc-beat-q4-2024-earnings-call-transcript-20250313.jpg
    HeartBeam, Inc. (BEAT) Q4 2024 Earnings Call Transcript

    seekingalpha.com

    2025-03-13 21:02:04

    HeartBeam, Inc. (NASDAQ:BEAT ) Q4 2024 Results Conference Call March 13, 2025 4:30 PM ET Company Participants Rob Eno - Chief Executive Officer Tim Cruickshank - Chief Financial Officer Operator Greetings, and welcome to the HeartBeam Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

    https://images.financialmodelingprep.com/news/heartbeam-to-participate-at-upcoming-conferences-in-dana-point-20250306.jpg
    HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025

    businesswire.com

    2025-03-06 09:01:00

    SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 17-21, 2025.

    https://images.financialmodelingprep.com/news/heartbeam-announces-exercise-and-closing-of-underwriters-overallotment-option-20250225.jpg
    HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock

    businesswire.com

    2025-02-25 16:01:00

    SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock.

    https://images.financialmodelingprep.com/news/heartbeam-announces-pricing-of-100-million-underwritten-public-offering-20250213.jpg
    HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock

    businesswire.com

    2025-02-13 08:31:00

    SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock.